Review ArticleSystematic Review
Open Access

Determinants of quality of life as measured with variants of SF-36 in patients with predialysis chronic kidney disease

Mohammed M. Alhaji, Jackson Tan, Mas RW Abdul Hamid, James A. Timbuak, Lin Naing and Nik AA Tuah
Saudi Medical Journal July 2018, 39 (7) 653-661; DOI: https://doi.org/10.15537/smj.2018.7.21352

References

  1. ↵
    1. Hill NR,
    2. Fatoba ST,
    3. Oke JL,
    4. Hirst JA,
    5. O'callaghan CA,
    6. Lasserson DS,
    7. et al.
    (2016) Global prevalence of chronic kidney disease. A systematic review and meta-analysis. PLoS One 11:1–18.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Jha V,
    2. Garcia-Garcia G,
    3. Iseki K,
    4. Li Z,
    5. Naicker S,
    6. Plattner B,
    7. et al.
    (2013) Chronic kidney disease: Global dimension and perspectives. Lancet 382:260–272.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Levin A,
    2. Tonelli M,
    3. Bonventre J,
    4. Coresh J,
    5. Donner JA,
    6. Fogo AB,
    7. et al.
    (2017) Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet 6736:1–30.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Lins L,
    2. Carvalho FM
    (2016) SF-36 total score as a single measure of health-related quality of life: scoping review. SAGE Open Med 4:2050312116671725.
  5. ↵
    1. Jesky MD,
    2. Dutton M,
    3. Dasgupta I,
    4. Yadav P,
    5. Ng KP,
    6. Fenton A,
    7. et al.
    (2016) Health-related quality of life impacts mortality but not progression to end-stage renal disease in pre-dialysis chronic kidney disease: a prospective observational study. PLoS One 11:e0165675.
    OpenUrlPubMed
  6. ↵
    1. Ware JE,
    2. Kosinski M
    (2001) Interpreting SF-36 summary health measures: a response. Qual Life Res 10:405-13–20.
    OpenUrl
  7. ↵
    1. Porter AC,
    2. Lash JP,
    3. Xie D,
    4. Pan Q,
    5. DeLuca J,
    6. Kanthety R,
    7. et al.
    (2016) Predictors and outcomes of health-related quality of life in adults with CKD. Clin J Am Soc Nephrol 11:1154–1162.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Aggarwal HK,
    2. Jain D,
    3. Pawar S,
    4. Yadav RK
    (2016) Health-related quality of life in different stages of chronic kidney disease. QJM 109:711–716.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Chong K,
    2. Unruh M
    (2017) Why does quality of life remain an under-investigated issue in chronic kidney disease and why is it rarely set as an outcome measure in trials in this population? Nephrol Dial Transplant 32(Suppl 2):ii47–ii52.
    OpenUrlPubMed
  10. ↵
    1. Clarke AL,
    2. Yates T,
    3. Smith AC,
    4. Chilcot J
    (2016) Patient's perceptions of chronic kidney disease and their association with psychosocial and clinical outcomes: A narrative review. Clin Kidney J 9:494–502.
    OpenUrlCrossRef
  11. ↵
    1. Chen SS,
    2. Al Mawed S,
    3. Unruh M
    (2016) Health-related quality of life in end-stage renal disease patients: how often should we ask and what do we do with the answer? Blood Purif 41:218–224.
    OpenUrl
  12. ↵
    1. Manavalan M,
    2. Priyamvada PS,
    3. Majumdar A,
    4. Kumar KTH
    (2017) Assessment of health-related quality of life and its determinants in patients with chronic kidney disease. Indian J Nephrol 27:37–43.
    OpenUrl
  13. ↵
    1. Peters MDJ,
    2. Godfrey CM,
    3. Khalil H,
    4. McInerney P,
    5. Parker D,
    6. Soares CB
    (2015) Guidance for conducting systematic scoping reviews. Int J Evid Based Health 13:141–146.
    OpenUrl
  14. ↵
    1. Pearson A,
    2. Field J,
    3. Jordan Z
    (2009) Appendix 3 data extraction tools. Evidence-Based Clin Pract Nurs Heal Care, 183–186.
  15. ↵
    1. Joanna Briggs Institute
    Critical Appraisal Tools, Available from: http://joannabriggs.org/research/critical-appraisal-tools.html.
  16. ↵
    1. Leech NL,
    2. Barrett KC,
    3. GA M
    (2014) IBM SPSS for intermediate statistics: Use and interpretation (Routledge, Abingdon (UK)), 5th ed.
  17. ↵
    1. Simms RJ,
    2. Thong KM,
    3. Dworschak GC,
    4. Ong ACM
    (2016) Increased psychosocial risk, depression and reduced quality of life living with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 31:1130–1140.
    OpenUrlCrossRefPubMed
  18. ↵
    1. Ibrahim N,
    2. Aini Pakri Mohamed R,
    3. Teo S,
    4. Che Din N,
    5. Halim Abdul Gafor A,
    6. Ismail R,
    7. et al.
    (2016) Association between health-related quality of life and psychological distress at different stages of chronic kidney disease. Sains Malaysiana 45:753–759.
    OpenUrl
  19. ↵
    1. Feng L,
    2. Yap KB,
    3. Ng TP
    (2013) Depressive symptoms in older adults with chronic kidney disease: Mortality, quality of life outcomes, and correlates. Am J Geriatr Psychiatry 21:570–579.
    OpenUrl
  20. ↵
    1. IBM Support
    (2016) ANOVA with summary data [Internet], Available from: http://www-01.ibm.com/support/docview.wss?uid=swg21476127. [cited 2017 June 4].
  21. ↵
    1. Mansur H,
    2. Colugnati FA,
    3. Grincenkov FR,
    4. dos S,
    5. Bastos M
    (2014) Frailty and quality of life: a cross-sectional study of Brazilian patients with pre-dialysis chronic kidney disease. Health Qual Life Outcomes 12:27.
    OpenUrl
  22. ↵
    1. Lemos CF,
    2. Rodrigues MP,
    3. Paulo Veiga JR,
    4. Veiga JRP
    (2015) Family income is associated with quality of life in patients with chronic kidney disease in the pre-dialysis phase: a cross sectional study. Heal Qual Life Outcomes 13:1–9.
    OpenUrl
  23. ↵
    1. Moher D,
    2. Liberati A,
    3. Tetzlaff J,
    4. Altman DG,
    5. Altman D,
    6. Antes G,
    7. et al.
    (2009) Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med 6:e1000097.
    OpenUrlCrossRefPubMed
  24. ↵
    1. Peng T,
    2. Hu Z,
    3. Guo L,
    4. Xia Q,
    5. Li D,
    6. Yang X
    (2013) Relationship between psychiatric disorders and quality of life in nondialysis patients with chronic kidney disease. Am J Med Sci 345:218–221.
    OpenUrlPubMed
  25. ↵
    1. Miskulin DC,
    2. Abebe KZ,
    3. Chapman AB,
    4. Perrone RD,
    5. Steinman TI,
    6. Torres VE,
    7. et al.
    (2014) Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: a cross-sectional study. Am J Kidney Dis 63:214–226.
    OpenUrlCrossRefPubMedWeb of Science
  26. ↵
    1. Delgado CEY,
    2. Jaramillo MM,
    3. Orozco BEO,
    4. Santaella MHC,
    5. Nunez JJY,
    6. Munoz JPL,
    7. et al.
    (2009) Quality of life in patients with chronic kidney disease without dialysis or transplant: a random sample from two insurance companies. Medellin, Colombia, 2008. Nefrologia 29:548–556, [Spanish].
    OpenUrlPubMed
  27. ↵
    1. National Kidney Foundation
    (2002) Clinical practice guidelines for chronic kidney disease: evaluation, clasification and stratification. American Journal of Kidney Diseases 39:1–356.
    OpenUrlCrossRefPubMedWeb of Science
  28. ↵
    1. Chin HJ,
    2. Song YR,
    3. Lee JJ,
    4. Lee SB,
    5. Kim KW,
    6. Na KY,
    7. et al.
    (2008) Moderately decreased renal function negatively affects the health-related quality of life among the elderly Korean population: A population-based study. Nephrol Dial Transplant 23:2810–2817.
    OpenUrlCrossRefPubMedWeb of Science
  29. ↵
    1. Mujais SK,
    2. Story K,
    3. Brouillette J,
    4. Takano T,
    5. Soroka S,
    6. Franek C,
    7. et al.
    (2009) Health-related quality of Life in CKD patients: Correlates and evolution over time. Clin J Am Soc Nephrol 4:1293–1301.
    OpenUrlAbstract/FREE Full Text
  30. ↵
    1. Lee SJ,
    2. Jeon JH
    (2015) Relationship between symptom clusters and quality of life in patients at stages 2 to 4 chronic kidney disease in Korea. Appl Nurs Res 28:e13–e19.
    OpenUrlCrossRef
  31. ↵
    1. Qaseem A,
    2. Hopkins RH,
    3. Sweet DE,
    4. Starkey M,
    5. Shekelle P,
    6. EM B,
    7. et al.
    (2013) Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: a clinical practice guideline from the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med 157:251–262.
    OpenUrl
  32. ↵
    1. Zimbudzi E,
    2. Lo C,
    3. Ranasinha S,
    4. Gallagher M,
    5. Fulcher G,
    6. Kerr PG,
    7. et al.
    (2016) Predictors of health-related quality of life in patients with co-morbid diabetes and chronic kidney disease. PLoS One 11:12.
    OpenUrlCrossRef
  33. ↵
    1. Liu WJ,
    2. Musa R,
    3. Chew TF,
    4. Lim CTS,
    5. Morad Z,
    6. Bujang A
    (2014) Quality of life in dialysis: A Malaysian perspective. Hemodial Int 18:495–506.
    OpenUrl
  34. ↵
    1. Tsai YC,
    2. Hung CC,
    3. Hwang SJ,
    4. Wang SL,
    5. Hsiao SM,
    6. Lin MY,
    7. et al.
    (2010) Quality of life predicts risks of end-stage renal disease and mortality in patients with chronic kidney disease. Nephrol Dial Transplant 25:1621–1626.
    OpenUrlCrossRefPubMedWeb of Science
  35. ↵
    1. McKercher C,
    2. Sanderson K,
    3. Jose MD
    (2013) Psychosocial factors in people with chronic kidney disease prior to renal replacement therapy. Nephrology 18:585–591.
    OpenUrlCrossRefPubMed
  36. ↵
    1. Wang MTM,
    2. Bolland MJ,
    3. Grey A
    (2015) Reporting of limitations of observational research. JAMA Intern Med 175:1571–1157.
    OpenUrl
    1. Hozo SP,
    2. Djulbegovic B,
    3. Hozo I
    (2005) Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 5:13.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section